Roche Diabetes Care India unveils ACCU-FINE pen needles for virtually painless insulin delivery

The ACCU-FINE needles are available in packs of 100 in three variants including a 33G 4mm variant, which is a first in India.;

Published On 2022-05-09 08:12 GMT | Update On 2022-05-09 10:24 GMT

Mumbai: Roche Diabetes Care India (RDC India) today announced the launch of ACCU-FINE, pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes.

This latest innovation from Roche Diabetes Care, makers of ACCU-CHEK, aims to make the process of insulin delivery easier thereby leading to better diabetes management for people with diabetes.

The ACCU-FINE needles are available in packs of 100 in three variants including a 33G 4mm variant, which is a first in India. Based on deep customer insights, the ACCU-FINE Pen Needles are specially designed with three key features to make them gentle in use. First, the needle has a special cut at the tip to ensure gentle insertion; second, the needle has a thin wall to enable rapid insulin flow; and third, the needle has a special coating that allows it to be inserted into the skin easily. The needles come with a sealed sterile protective cap and an additional protective cap for double protection.

Read also: Roche Diabetes Care appoints Omar Sherief Mohammad as India, Middle East & Africa head

Speaking about this launch, Omar Sherief, Cluster Head – India Middle East and Africa, RDC said, "An important part of successful diabetes management is regular and timely insulin delivery. The process of injecting is sometimes unpleasant for people with diabetes, causing fear.

This often leads to insulin initiation delay which is closely associated with poor glycemic control and further clinical complications. In keeping with our commitment to #PutPatientsFirst, we believe that our ACCU- FINE Pen Needles will make the insulin initiation experience easier & virtually painless for people with diabetes. With this initiative we are one step closer to helping people with diabetes manage their condition better."

The product is already available for purchase in pharmacies across the Indian market.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Roche Diabetes Care India unveils ACCU-FINE pen needles for virtually painless insulin delivery

The ACCU-FINE needles are available in packs of 100 in three variants including a 33G 4mm variant, which is a first in India.;

Similar News

Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer

NPPA fixes Special Ceiling Price for Gufic's Meropenem Dual Chamber Bags

Sun Pharma Fails to Secure CDSCO Nod for BE, Phase III Waiver on Sitagliptin, Glimepiride, Metformin FDC

USFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand Disease

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Drug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and Metoclopramide

Virchow Biotech gets CDSCO panel nod to study Semaglutide for chronic weight management

SC Questions Effectiveness of UCPMP, Seeks Govt Clarification on Pharma Freebies